Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Novo Holdings Leads US$ 118M Series C Investment in Genomatica
2 Novo Holdings A/S Invests in US Healthcare IT Company Availity PR Newswire 1 day ago
3 Novo Nordisk Education Foundation launches chatbot Mishti for diabetes management
4 Novo Nordisk Education Foundation introduces Mishti
5 Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
6 The Novo Nordisk Foundation establishes BioInnovation Institute as an independent foundation to provide long-term and ambitious support for innovation in life sciences
7 Novo Nordisk Education Foundation Brings Out Chatbot For Diabetes Information
8 New CEO of the Novo Nordisk Foundation
9 Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
10 Jesper Brandgaard New Chairman of the Board of Directors of LEO Pharma
11 Novo Nordisk Foundation partners with C-CAMP for Covid emergency hospitals
12 Neural “Vicious Cycle” in Fatty Liver Disease Revealed in New 3D Imaging
13 Novo Nordisk's long-term chief scientific officer Thomsen retires, becomes its foundation chief
14 Walmart teams up with Novo Nordisk to launch private-brand analog insulin
15 Lilly wagers up to $1B on a biotech's plan for a new type of insulin
16 Novo Nordisk Foundation puts up €100M for green manufacturing
17 Chronic Hypoparathyroidism Associated With Normal, Low-Risk Pregnancy Outcomes
18 Walmart launches low-priced own brand analog insulin in US
19 Ferring Pharmaceuticals Announces Changes to Board of Directors
20 Novo Nordisk Foundation Commits €100M to Finance Green Tech
21 Novo Holdings acquires BBI Group
22 Mads Krogsgaard Thomsen hands off CSO job at Novo Nordisk after a 30-year run, then pivots to CEO post at huge Novo Foundation
23 Novo Holdings Leads US$200M Series A investment in Asia-based Life Sciences Tools Company Esco Lifesciences Group
24 Science News Releases
25 Novo Nordisk A/S purchases B shares worth DKK 2,913 million
26 Biohackers Are Working to Make Insulin 98% Cheaper
27 High blood sugar levels reprogramme stem cells
28 Novo Nordisk A/S purchases B shares worth DKK 2,586 million
29 Novo Nordisk owner, Danish government in talks about vaccine production
30 12-cr grant from Danish foundation to boost efforts
31 Novo Nordisk Foundation Awards $27 Million to Improve Bioindustry and Green Activities
32 Investing in innovative biotechs with Novo Ventures
33 Novo Holdings invests in Hemab, a company going against the hemophilia gene therapy grain with a plan for bispecifics
34 Insulin maker Novo Nordisk walks moral tightrope
35 Seattle startup Lumen Bioscience to build algae manufacturing plant in former bakery
36 Huber Needles Services Market Research Report, Growth Trends and Competitive Analysis 2021-2027 – The Manomet Current
37 How basic physics and chemistry constrain cellular functions in primitive and modern cells
38 Stocks Held by the Bill and Melinda Gates Foundation
39 Significant Growth in Benzalkonium Chloride Market by 2021-2027 with Profiling Key Players | Novo Nordisk, Dishman Group, Jinshan Jingwei Chemical – The Manomet Current
40 Novo Holdings makes its first investment in an Asian health tech company
41 Proteomics reveals how exercise increases the efficiency of muscle energy production
42 Researchers want to create an entirely new category of climate-friendly plant-based foods
43 Investor of the week: Novo Holdings
44 Novo Holdings REPAIR Impact Fund Announces Second Global Call for New Investment Proposals to Fight AMR
45 Audax Private Equity Completes Sale of Altasciences to Novo Holdings
46 Proteomics Market worth $ 73.17 Billion, Globally, by 2028 at 16.50% CAGR: Verified Market Research™
47 BRIEF- Novo Nordisk And Lumen To Explore Strategies On ...
48 Global and Japan Recombinant Protein Drugs Service Market Size 2021 by Product Sales, Revenue, Price, Market Share, Growth Opportunity and Forecast to 2027 Research Report I Top key players-Pharmaceutical Industry, Others & Others – The Mano
49 BioMedical Design Novo Nordisk Foundation Fellowship Programme
50 BioInnovation Institute takes in new cohort of promising early-stage innovations
51 Novo Nordisk A/S – Share repurchase programme
52 Revisiting Novo Nordisk
53 Novo Holdings bolsters Principal Investments team with key US appointments
54 Why Novo Nordisk Is Still a Top Stock for 2021
55 Technical University of Denmark: New academy is to strengthen data science in Denmark
56 Cities Changing Diabetes announces five new programs to fight diabetes and obesity in Philadelphia
57 | Genomeweb
58 Novo Nordisk Ends Development of NN9828, Shifts Focus to Pandemic Initiatives
59 Novo Nordisk ups guidance after Q1 results beat expectations
60 Combination liraglutide plus exercise improves weight-loss maintenance in obesity
61 Novo Nordisk (NVO) Semaglutide Gets FDA Nod for Obesity
62 Novo Nordisk certified as one of the Best Places to Work in Thailand
63 Novo Holdings expands investment scope to Asia
64 Brain can induce diabetes remission in rodents, but how?
65 Novo Nordisk Pharmatech's New CEO Has a Head Start
66 Former Novo Nordisk Executive, Dr. Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer
67 Sunstone welcomes Novo Holdings A/S as new LP in Sunstone Life Science Ventures Fund IV
68 Researchers solve 'protein paradox' and suggest way to exploit cancer weakness
69 Novo Nordisk (NVO) Inks Deal to Develop Heart Failure Treatment
70 New research will unveil the future for natural preservation of food products
71 Habener Receives Gairdner Award | Harvard Medical School
72 Exercise, Liraglutide Combo Superior for Weight Loss Maintenance
73 Dicerna Announces Novo Nordisk's Nomination of First Candidate for Development Under RNAi Discovery and Development Agreement and Additional Milestone Achievement
74 Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 26, 2021
75 Researchers test whether feces transplantation can help patients with cirrhosis of the liver
76 Gilead and Novo Nordisk advance NASH collaboration to larger clinical study
77 Novo Nordisk Plans To Initiate Phase 3a Development In Obesity With Oral Semaglutide
78 Novo Nordisk Education Foundation unveils second-year report of Impact India: 1000-day Challenge
79 Novo Nordisk (NVO) Files for Semaglutide Label Expansion in EU
80 Novo Nordisk-backed NREP raises record real estate fund
81 Novo Nordisk A/S purchases B shares worth DKK 2,235 million
82 Novo Nordisk: Poised To Profit As The Lockdowns Make The Obesity Crisis Worse
83 16 Tips for Affording Your Diabetes Medications and Supplies
84 Boehringer gets into 'guided-missile drugs' with $1.5 billion deal for NBE
85 Novo Nordisk Sets Up Insulin Production Line in Iran — Bourse & Bazaar Foundation
86 Six-Year Research Project To Ferment ‘New Category’ Of Plant-Based Protein
87 Novo Nordisk (NVO) Files for Ozempic's Label Expansion in EU
88 Novo Nordisk Recalls Levemir, Tresiba, Fiasp, Novolog, Xultophy Product Samples
89 Research project to eliminate 'forever chemicals'
90 Team Novo Nordisk partner with Swedish sports nutrition pioneers Maurten for 2021 and beyond
91 Novo Nordisk's new CEO leads it through its first tough period
92 Quantum technologies can transform innovation and mitigate climate change – here's how
93 Numab raises $110m to develop cancer bispecific antibodies
94 The body produces new satiety factor during prolonged exercise
95 Novo Ventures and Broad Institute of MIT and Harvard Launch Drug Discovery “Greenhouse” to Drive Creation of Innovative New Therapies
96 Solving the MCM Paradox and What It Means for Cancer
97 Lars Rebien Sørensen: It makes no sense for countries to develop vaccines individually
98 How to Afford Your Insulin: Resources and Tips
99 Polyamine and Polyamine Analogue Biosynthesis May Help Treat and Prevent Age-Related Diseases
100 Danish pharma giant Novo Nordisk makes Istanbul regional management hub | Daily Sabah